INTRODUCTION

All carcinoid tumors, wherever they show up, affect cells that make hormones. They are part of a group of diseases called neuroendocrine tumors (NETs).

Most carcinoid tumors start in one of two areas: your lungs or your digestive system, also known as the GI tract. That includes places like your stomach, small intestine, colon, appendix, or rectum.

RISKS FOR CARCINOID TUMORS

• Genetic disease
• Race
• Gender
• Age

SYMPTOMS

• Pain in your belly
• Diarrhea
• Constipation
• Feel nauseated or throw up
• Cannot breathe right
• Get blood in your stool
• Lose weight

HOW ARE CARCINOID TUMORS DIAGNOSED?

• Biopsy
• Blood and urine tests
• Upper endoscopy
• Colonoscopy
• Capsule endoscopy
• Computed tomography
• MRI
• X-ray
• Radionuclide scanning

TREATMENT

Radiation: It uses high-energy X-rays to kill cancer cells. Most of the time you get this from a machine outside your body. Or the doctor can implant radioactive seeds inside your body, near the tumor. Side effects can include fatigue and redness in the treated area. If you get radiation to the neck or throat, you may have a sore throat, cough, shortness of breath.

Chemotherapy: It uses drugs to stop cancer cells from growing. You might take these in the form of pills or get them put into you through a vein. Your doctor may use this treatment if your disease has spread. Side effects of chemo include nausea, vomiting, hair loss, loss of appetite, and a higher risk for infections.

CONCLUSION

Our Journal is planning to release a year end special issue has announced almost 50% discount on article publication charges to celebrate its journey for publishing articles with in the short time.

The Journal will publish original articles, reviews, technical notes, editorials, news and views (commentaries, science policy issues, ethical and legal issues, patient organizations, industry needs and alliances, regulatory issues, etc.), and letters to the editor.

The Journal invites different types of articles including original research article, review articles, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication.

 The Journals includes around 150Abstracts and 100 Keynote speakers have given their valuable words. The meet has provided a great scope for interaction of professionals including in addition to clinical experts and top-level pathologists and scientists from around the globe, on a single platform.

 Media Contact:
ALPINE
Managing Editor
Journal of Molecular Oncology Research
Email: oncology@openaccessjournal.org